Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form

Market Reports

Review: Cannabis Europa 2019

Review: Cannabis Europa 2019

Scientists, businesspeople and politicians backing the regulation of medical and recreational cannabis have taken the stage of Southbank Centre this week to discuss research and business opportunities
Register now: Lab Innovations celebrates Year of the Periodic Table

Register now: Lab Innovations celebrates Year of the Periodic Table

Event in Birmingham will feature 35 hours of educational CPD-accredited seminars and the Cleanroom Hub in partnership with <em><a href='http://www.cleanroomtechnology.com'>Cleanroom Technology</a></em> magazine
CMC strategies for the acceleration of commercial-ready ADC manufacturing

CMC strategies for the acceleration of commercial-ready ADC manufacturing

The potential for antibody-drug conjugate (ADC) programmes to accelerate from early to late stage clinical development highlights the need to establish commercial launch-ready manufacturing early and efficiently, reports Courtney Morgret, Senior Scientist, Manufacturing Sciences, AbbVie
Video: Silverson manufactures 19ft Duplex Disintegrator mixer in-house

Video: Silverson manufactures 19ft Duplex Disintegrator mixer in-house

Multimedia showcases the largest batch mixer in the Silverson range as it comes to life
ECH Medical to open the UK's first standalone cannabis clinic

ECH Medical to open the UK's first standalone cannabis clinic

Company has also facilitated the import of the UK's first bulk shipment of cannabis-based medicine
Blockchain: the key to a secure pharmaceutical supply chain

Blockchain: the key to a secure pharmaceutical supply chain

Pharmaceutical companies are increasingly exploring solutions to combat counterfeiters, reports Tom Egan, Vice president, Industry Services, PMMI, Rick Fox, President and CEO, FOX IV Technologies, and Bill McBeath, Chief Research Officer, Chainlink Research
GEA supplies Bracco with falling film evaporator for contrast media

GEA supplies Bracco with falling film evaporator for contrast media

The evaporator Bracco has ordered is specifically designed for use in the production of Iodoftal
Delivering higher value diagnostics

Delivering higher value diagnostics

Dr Kevin Robinson had a discussion with Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, following EuroMedLab, regarding how enhancing lab technology, including automated maintenance, is helping to reduce manual operations and the risk of errors
The future of pharmacovigilance and the impact of automation

The future of pharmacovigilance and the impact of automation

Pharmacovigilance (PV), the process of identifying, tracking, evaluating and preventing negative outcomes from drug therapies, is a sector that has seen huge growth in recent years. David J. Balderson, Vice President, Global Safety Operations, Sciformix, a Covance company, reports
Butterfly valves: Containment and monitoring for API transfer

Butterfly valves: Containment and monitoring for API transfer

Michael Avraam of Chargepoint Technology writes about systems that are critical to preventing HPAPIs harming staff and the bottom line
Establishing a secure supply chain for phyto-APIs

Establishing a secure supply chain for phyto-APIs

APIs produced from naturally derived materials can be challenging to supply reliably and with consistently high quality. C<sup>2</sup> PHARMA has implemented multiple solutions to ensure supply chain security
Serving up finance

Serving up finance

OEMs can help their customers in the pharmaceutical sector to embrace digitalisation with integrated finance, reports Gary Thompson, Sales Director, Siemens Financial Services (UK)
Building a new business model with method lifecycle management

Building a new business model with method lifecycle management

An increased focus on lifecycle management for analytical methods has been seen in recent years from the industry’s regulatory bodies. Method lifecycle management (MLCM) provides an opportunity to continuously improve and ensure quality of data through the application of quality risk management
A natural remedy for brain metastasis

A natural remedy for brain metastasis

Milk thistle extract might be a promising complementary treatment for cancer patients, reports Andrea Zangara, Scientific Marketing Manager, Euromed
The Manufacturing Chemist outsourcing roundtable: part II

The Manufacturing Chemist outsourcing roundtable: part II

Having talked about upcoming trends, potential growth and in-demand services in Part I, I open the second session by asking the panellists whether they’ll be investing in any particular aspects of their businesses during the next 12 months
A matter of material choice

A matter of material choice

Dr Kevin Robinson recently caught up with DuPont’s Eric Schmohl, Global Marketing Manager for Tyvek Pharmaceutical Packaging, and Jean-François Teneul, Global Life Sciences Market Leader of Tyvek Protective Apparel, to discuss the importance of protecting both people and product during aseptic fill-&-finish processes
  • Previous
  • 1
  • …
  • 8
  • 9
  • 10
  • 11 (current)
  • 12
  • 13
  • 14
  • 15
  • Next

Trending Articles

  1. A rules-based approach to labelling and artwork management: Part I Many organisations today are experiencing unprecedented demands from regulatory authorities and consumers alike for product labelling to be made clearer and more informative, says Graham Francis, Channel Marketing Manager, Kallik
  2. A microfluidic approach to production of alginate beads for cell encapsulation Gurinder Vinner, Material Scientist at Dolomite Microfluidics, discusses the benefits of continuous microfluidic production for the encapsulation of mammalian cells with no loss of viability
  3. Recombinant versus synthetic peptide synthesis: the perks and drawbacks Since the introduction of novel peptide drugs into the market, the demand for polypeptide manufacturing has significantly increased, reports Dr Philipp Markolin
  4. UK pharma shifts as Merck and AstraZeneca scale back: can CDMOs fill the gap? Recent major site withdrawals and investment pauses have raised concerns about the UK’s industrial strength. But CDMOs say agility, innovation and technical expertise could redefine how and where drugs are made
  5. CMC strategies for the acceleration of commercial-ready ADC manufacturing The potential for antibody-drug conjugate (ADC) programmes to accelerate from early to late stage clinical development highlights the need to establish commercial launch-ready manufacturing early and efficiently, reports Courtney Morgret, Senior Scientist, Manufacturing Sciences, AbbVie

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.